CancerCare has compiled these most promising findings in its new booklet, Your Guide to the Latest Cancer Research and Treatments: Highlights from ASCO 2011, available online now. You can also order your free copies from our publications page.

• The Importance of Taking Your Pills Everyday on Schedule offers tips on how patients can adhere to their doctor’s instructions and remember to take their pills.
• Colorectal Cancer: The Importance of Screening and Early Detection describes the screening tests that are available to detect and also prevent colorectal cancer.
• Coping with Peripheral T-cell Lymphoma (PTCL) offers helpful tips for managing the practical and emotional concerns people may have after being diagnosed with peripheral t-cell lymphoma (PTCL).
• Update on the Treatment of Liver Cancer details the different types of liver cancer, their treatment options, how to manage side effects, and the importance of communicating with your health care support team.
• Latest News in Blood Cancer Research presents the latest research in the treatment of leukemia, lymphoma, and multiple myeloma.

Three of these new publications are in Spanish:

• Lidiando con las nauseas y vomitos inducidos por la quimioterapia (Coping with Chemotherapy-Induced Nausea and Vomiting) (CINV)) offers tips for coping with nausea and vomiting from chemotherapy treatment.
• Mieloma multiple: Obtenga el maximo de sus citas medicas (Multiple Myeloma: Making the Most of Your Medical Appointments) explores ways to improve communication with your health care team.  
• Sobrellevando el mieloma multiple (Coping with Multiple Myeloma) offers tips for managing multiple myeloma so that patients can feel more in control of their diagnosis.  

Stay up-to-date on new publications by signing up for CancerCare E-News, CancerCare‘s free monthly email newsletter.

Some of the year’s most promising findings included:

Melanoma: For the first time ever, a new drug extended the lives of people whose melanoma no longer responds to other treatments and has spread beyond the skin to other parts of the body. (Learn more about CancerCare‘s free support services for people affected by melanoma).

Lung Cancer: Researchers reported that older patients with advanced non-small cell lung cancer can be safely and effectively treated with more aggressive chemotherapy. Researchers also reported that supportive care not only improves the quality of life for people with metastatic lung cancer, but also extends their lives. (Visit www.lungcancer.org to learn about CancerCare‘s free resources for people diagnosed with lung cancer and their loved ones).

Blood and Lymph Cancers: For the first time, drugs such as lenalidomide (Revlimid) can be used not only to treat newly diagnosed or relapsed myeloma, but also as therapies to keep myeloma from coming back after successful first-time treatment. (CancerCare provides individual transportation grants to people with multiple myeloma through our “Door to Door” program, along with a wide range of additional free support services).

Head and Neck Cancer: Researchers discovered that testing a patient’s human papillomavirus (HPV) status helps doctors craft more effective treatments for the patient. (CancerCare helps people affected by head and neck cancer and their loved ones through free support services including counseling, support groups, education, financial assistance, and referrals to other resources).

Read the entire booklet online, or order free copies from our website.

Visit the study’s website to learn about what MAGRIT involves, if you are eligible for this study, and to find a study center close to you. It’s best to consult with your doctor first to determine whether you should participate.

CancerCare offers reliable information about clinical trials and how they can improve the quality of your care. You can read our free booklets and fact sheets about lung cancer and clinical trials directly on our website. In addition, on Friday, September 24, leading experts on clinical trials will answer your questions and concerns in the Connect Education Workshop, The Important Role of Clinical Trials. Register for the live discussion here.

Through the CancerCare Co-Payment Assistance Foundation, people undergoing treatment for non-small cell lung cancer who have health insurance coverage may be eligible to receive up to $10,000 per year in co-payment assistance.

You can help show your support for people facing lung cancer by participating in CancerCare’s 8th annual Lung Cancer Walk. This year, the walk will be held in two locations: on Sunday, November 7 in Woodbury, NY, and on Sunday, November 14, in Palo Alto, CA.  The Walks raise funds to support CancerCare‘s free, professional services for anyone affected by lung cancer. To register,  visit our Lung Cancer Walk website.

To learn more about lung cancer and CancerCare’s services for people affected by lung cancer, visit lungcancer.org.

When Suzanne Lindley was diagnosed with colorectal cancer and informed she had six months to live, she and her family moved to the country, where she’d always dreamed of living.  Twelve years later, Suzanne leads an amazingly active life, traveling all around the country as a colorectal cancer advocate.

She credits her current quality of life to hitchhiking treatments, as well as to her CancerCare social worker Keith Lyons, who provided her with essential support and motivation through individual counseling and a support group.  “[Keith] said I could see cancer as a death sentence or I could celebrate the fact that I was very much alive and experience now,” Suzanne recalls.

The complete article is available here.

CancerCare offers online, telephone and face-to-face support groups that connect you with people who are in a similar situation. All support groups are free and led by professional oncology social workers who are experienced with cancer-related issues and concerns.

The guidebook was written by Vladimir Lange, M.D. to empower patients to seek a cure, rather than to accept defeat.  “New treatments, new drugs, and earlier diagnosis make survival much more likely than it was just a few years ago,” he notes.

CancerCare Lung Cancer Program Coordinator Win Boerkel calls Be a Survivor “one of the best lung cancer patient guides I’ve seen in my 13 years of working with lung cancer patients.”

In 2009, CancerCare collaborated with leading patient advocacy groups to launch The Lung Cancer Clinical Trial Call to Action campaign, designed to help patients and their families navigate the complicated landscape of researching and identifying clinical trials. Patients can call 1-800-698-0931 to be matched with a Clinical Trial Specialist who will guide them through the entire process.

The CancerCare Co-Payment Assistance Foundation offers up to $10,000 per year in co-payment assistance for lung cancer patients in their families.

To order the guide, call 1-888-LANGE-88 (888-526-4388), or print out and fax back the order form.

Learn more about our free services for lung cancer patients and visit our sister website, www.lungcancer.org.

The Lung Cancer Clinical Trial Call to Action campaign offers easy-to-use educational and trial-matching resources to help identify clinical trials that are appropriate to each patient’s diagnosis, stage and treatment history.

The campaign is a collaboration of six leading patient advocacy organizations, including CancerCare’s lungcancer.org, a leading resource for people affected by lung cancer.

Patients can access the Lung Cancer Clinical Trial Matching Service online by visiting www.lungcancer.org or by calling 1-800-698-0931, to speak directly with a clinical trial specialist who can guide them through the entire process.

Other organizations in the campaign include the Lung Cancer Alliance, Uniting Against Lung Cancer, National Lung Cancer Partnership, LUNGevity and the Respiratory Health Association of Metropolitan Chicago. EmergingMed is the service provider for the Lung Cancer Clinical Trials Matching Service.

The effort is being supported by several major pharmaceutical companies dedicated to the fight against lung cancer, including Boehringer Ingelheim Pharmaceuticals, Inc., Amgen Inc., AstraZeneca, Genentech BioOncology, and Pfizer Oncology.

Over 200,000 people will be diagnosed with lung cancer in 2009. Lung cancer not only affects patients but also families and loved ones. CancerCare offers free, professional counseling and practical support to anyone coping with a lung cancer diagnosis through its National Lung Cancer Program.

In addition, CancerCare‘s online resource, www.lungcancer.org, provides reliable information to anyone affected by lung cancer. Learn more about the full range of services CancerCare offers to people facing lung cancer, including: counseling, support groups, financial assistance, publications and educational workshops.

You can also read stories of people who are coping with lung cancer and share your own story to help inspire others; and post a message in honor of a loved one on our Virtual Wall of Hope.

Listen to CancerCare‘s upcoming Connect Education Workshops over the telephone or via live streaming through the internet (registration is required):

Dec. 9 - Clinical Trials: Improving Treatment Options and Care for People Living with Cancer
Jan. 15 - Understanding Adjuvant Therapy for Early-Stage Lung Cancer

To speak directly to an oncology social worker, call us at 1-800-813-HOPE (4673).

A recent article  in the New York Times explores the reasons why clinical trial enrollment is so low and how researchers are working to change this through new methods of patient selection that would require far fewer than the usual 5,000-10,000 patients needed for each trial.

For more information on finding upcoming or ongoing clinical trials, visit www.clinicaltrials.gov and www.emergingmed.com.

All CancerCare publications are completely free of charge and can be ordered directly from our website.